| Name | Fisher Eye Care Clinic Llc |
|---|---|
| Organization Name | Fisher Eye Care Clinic Llc |
| Location | 230 10th St, Windom, Minnesota 56101 |
| Type | Supplier |
| Phone | (507) 831-3478 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Citing the devastating impact that pending Medi-Cal payment cuts would have on the North State's most vulnerable patients, local hospital leaders in Redding today joined with patient families to call on state lawmakers to enact new legislation that would preserve the state's health care safety net.
Researchers in China have conducted a study showing that a carbohydrate found in the seaweed Ecklonia kurome blocks the activity of an enzyme that is essential for the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Scientists at The Scripps Research Institute (TSRI) have made a major advance in understanding how flu viruses replicate within infected cells. The researchers used cutting-edge molecular biology and electron-microscopy techniques to "see" one of influenza's essential protein complexes in unprecedented detail. The images generated in the study show flu virus proteins in the act of self-replication, highlighting the virus's vulnerabilities that are sure to be of interest to drug developers.
"It is disappointing that the Senate is determined to fund health care reform by restricting access to flexible spending accounts (FSAs), a valuable benefit relied upon by more than 35 million Americans to help hold down health care costs. Severely curtailing the use of FSAs will not only force participants to pay more in health care costs, it flies in the face of President Obama's pledge to not raise taxes on the middle class.
Global regenerative medicine company Mesoblast Limited (ASX:MSB) has announced that its Phase 2 clinical trial investigating the use of allogeneic, or off-the-shelf, Mesenchymal Precursor Cells (MPCs) for non-surgical restoration of degenerated intervertebral discs and treatment of low back pain has enrolled 50% of the total study patients. This rapid rate of enrolment attests to the major unmet medical need and to the relative simplicity of Mesoblast's non-surgical procedure. Mesoblast expects to complete full enrolment by early third quarter.
› Verified 5 days ago
News Archive
Citing the devastating impact that pending Medi-Cal payment cuts would have on the North State's most vulnerable patients, local hospital leaders in Redding today joined with patient families to call on state lawmakers to enact new legislation that would preserve the state's health care safety net.
Researchers in China have conducted a study showing that a carbohydrate found in the seaweed Ecklonia kurome blocks the activity of an enzyme that is essential for the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Scientists at The Scripps Research Institute (TSRI) have made a major advance in understanding how flu viruses replicate within infected cells. The researchers used cutting-edge molecular biology and electron-microscopy techniques to "see" one of influenza's essential protein complexes in unprecedented detail. The images generated in the study show flu virus proteins in the act of self-replication, highlighting the virus's vulnerabilities that are sure to be of interest to drug developers.
"It is disappointing that the Senate is determined to fund health care reform by restricting access to flexible spending accounts (FSAs), a valuable benefit relied upon by more than 35 million Americans to help hold down health care costs. Severely curtailing the use of FSAs will not only force participants to pay more in health care costs, it flies in the face of President Obama's pledge to not raise taxes on the middle class.
Global regenerative medicine company Mesoblast Limited (ASX:MSB) has announced that its Phase 2 clinical trial investigating the use of allogeneic, or off-the-shelf, Mesenchymal Precursor Cells (MPCs) for non-surgical restoration of degenerated intervertebral discs and treatment of low back pain has enrolled 50% of the total study patients. This rapid rate of enrolment attests to the major unmet medical need and to the relative simplicity of Mesoblast's non-surgical procedure. Mesoblast expects to complete full enrolment by early third quarter.
› Verified 5 days ago
Avera Medical Group Optometry Windo Type: Medicare Supplier Location: 1006 4th Ave, Windom, Minnesota 56101 Phone: (507) 831-2429 | |
Fisher Eye Care Clinic Llc Type: Medicare Supplier Location: 230 10th St, Windom, Minnesota 56101 Phone: (507) 831-3478 | |
Hy-vee Pharmacy (1892) Type: Community/Retail Pharmacy Location: 192 10th St, Windom, Minnesota 56101 Phone: (507) 832-8230 | |
Lewis Family Drug #56 Type: Long Term Care Pharmacy Location: 599 2nd Ave N, Windom, Minnesota 56101 Phone: (507) 831-4161 | |
Sanford Home Medical Equipment Type: Durable Medical Equipment & Medical Supplies Supplier Location: 585 2nd Ave N, Windom, Minnesota 56101 Phone: (507) 831-0247 |